Daly James M reported grant involving 4,301 derivative units of CYTOKINETICS INC at $0.00 for $0 on May 27, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 27, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
4,301Non-Qualified Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
4,301Direct
Trade date
May 27, 2026Grant
Filed
May 27, 2026, 7:14 PM ET0-day reporting delay
Accession
0001061983-26-000061Code A · Transaction 91403
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 27, 2026Grant2,851$0.00$0Trade 91402
2 transaction rows in this filing. Joint filers share the same rows.

CYTK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CYTK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −20%1w ago +2.1%1d ago −1.1%
Returns since7d −8.4%30d +6.5%90d +1.3%180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.